.png)
Octapharma is one of the largest human protein product manufacturers in the world headquartered in Lachen, Switzerland. They develop and produce medicines based on human proteins from human cell lines and human plasma, sourced from our own plasma donation centres and other external sources. The doctors and scientists at Octapharma focus on three therapeutic areas: haematology, immunotherapy and critical care, and the products are available in 118 countries and reach hundreds of thousands of patients every year.
The Industrial Business Team of Octapharma in Europe had been using Salesforce for almost 2 years and was happy with the CRM functionalities. To reflect the joint global business structure, they wanted the US as well as China team to onboard. Their processes, however, had some differences, which needed to be accounted for. Activities, as well as sales data for the Industrial Business, were not tracked within Salesforce on a global scale which resulted in incomplete account information. Moreover, quality-related activities were not reflected in the CRM system leading to non-conclusive account history. This needed to change.
The EMPAUA team took a holistic approach to the design and implementation of Salesforce solutions. In this way, we ensured that every stage of Octapharma's launch process was captured in an easy-to-use system. Among the advanced solutions that the EMPAUA team implemented were:
The results of the implementation showed positive signs from day one. The EMPAUA team is extremely proud to see that among the most important results of this project are:
.png)
.png)
.png)